Journal of Clinical Medicine of Kazakhstan, 2026, т. 23, № 4, с. 14-24
Effectiveness and Safety of Lanadelumab in the Treatment of Patients with Hereditary Angioedema in Routine Clinical Practice in the Russian Federation.
Department of Immunopathology, National Research Center – Institute of Immunology Federal Medical-Biological Agency, Moscow, Russia
Department of Clinical Immunology and Allergology, Saratov State Medical University named after V.I. Razumovsky, Saratov, Russia
Moscow City Research and Practical Center of Allergy and Immunology, City Clinical Hospital 52, Moscow Healthcare Department, Moscow, Russia
Department of Clinical Immunology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation
Department of Allergology and Immunology, Smolensk Clinical Hospital №1, Regional Center of Allergology and Immunology, Smolensk, Russian Federation
Counselling outpatient clinic, Vologda regional clinical hospital, Vologda, Russian Federation
Department of Allergology, Research Institute of Fundamental and Clinical Immunology, Novosibirsk, Russian Federation
Department of Clinical Medicine, Murmansk Arctic University, Murmansk, Russian Federation
Consultative and diagnostic department, Sverdlovsk Regional Clinical Hospital, Ekaterinburg, Russian Federation
Department of Pulmonology, Republican Hospital named after V.A. Baranov, Petrozavodsk, Republic of Karelia, Russian Federation
Clinical and diagnostic department, DOCMED clinic
Moscow City Research and Practical Center of Allergy and Immunology, City Clinical Hospital 52, Moscow Healthcare Department, Moscow, Russian Federation; Department of Clinical Immunology and Allergy, The First Sechenov State Medical University, Moscow, Russia
Аннотация · Abstract
Сведения · Details
- DOI 10.23950/jcmk/18883
- Журнал · Journal Journal of Clinical Medicine of Kazakhstan
- Язык · Language английский
- Цитирования (Crossref) · Citations 0